The Addition of Bevacizumab to Standard Radiation Therapy and Temozolomide Followed by Bevacizumab, Temozolomide and Irinotecan for Newly Diagnosed Glioblastoma

PURPOSE: To determine if the addition of bevacizumab to radiation therapy and temozolomide, followed by bevacizumab, temozolomide and irinotecan for newly diagnosed glioblastoma patients is safe and effective. EXPERIMENTAL DESIGNS: Seventy five patients with newly diagnosed glioblastoma were enrolle...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Vredenburgh, James J., Desjardins, Annick, Reardon, David A., Peters, Katherine B., Herndon, James E., Marcello, Jennifer, Kirkpatrick, John P., Sampson, John H., Bailey, Leighann, Threatt, Stevie, Friedman, Allan H., Bigner, Darell D., Friedman, Henry S.
Format: Artigo
Idioma:Inglês
Publicat: 2011
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3117928/
https://ncbi.nlm.nih.gov/pubmed/21531816
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-11-0120
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars